Navigation Links
Scientists favor needles over tablets for global vaccinations
Date:4/26/2010

Saranac Lake, N.Y. - According to the World Health Organization, two billion people around the globe suffer from chronic parasitic worm infections, which, in addition to causing illness and developmental delay, are also suspected to interfere with the effectiveness of ordinary vaccines, making their victims more vulnerable to life-threatening diseases. A recent discovery by researchers at the Trudeau Institute promises to bypass these obstacles and help deliver more effective vaccines to these people, boosting their protection against common childhood diseases.

Dr. Markus Mohrs and his team of investigators focus much of their studies on cytokines, messengers used by cells of the immune system to communicate with one another. Cytokines help determine both the size and the quality of our immune system's response to an infection. How well they perform their job can decide whether it's the person or the pathogen that wins the battle for survival.

Despite their obvious importance, however, surprisingly little is known about how far or for how long cytokines can operate during an infection.

New findings, reported in the current issue of the journal Nature Immunology, reveal when and where cytokine signals are received in the body. Dr. Mohrs reports that cytokines not only signal locally to neighboring cells, as previously thought, but they also spread throughout the affected lymph node influencing even those cells not actively involved in fighting the current infection.

The indiscriminate action of the cytokines means that these bystander cells may respond inappropriately when the immune system encounters a different infection and it becomes their turn to react.

The findings provide a potential explanation for the ability of chronic infections to alter immune responses to subsequent infections or vaccination procedures. This is particularly important for the design of vaccines in the developing world, where chronic parasitic infections can derail vaccination programs that are effective in healthy individuals.

Because only bystander cells in the same lymph node as those responding to the parasite infection are affected by active cytokines, this study suggests that people infected with gastrointestinal worms may respond better to vaccines injected under the skin than those given by mouth. This is critical information for the development of globally-effective vaccination strategies.

Although the current study will not necessarily lead to improved treatments for worm infections themselves, by understanding how worm infection affects other immune responses, scientists may be able to improve the efficacy of ordinary vaccines like those used to prevent polio, measles, malaria and TB in those regions of the world where most children are already infected with parasitic worms prior to receiving their childhood immunizations.


'/>"/>

Contact: Brian Turner
bturner@trudeauinstitute.org
518-891-3080
Trudeau Institute
Source:Eurekalert  

Related biology news :

1. Phosphorous in sodas and processed foods accelerates signs of aging say Harvard scientists
2. Scientists crack code of critical bacterial defense mechanism
3. Scientists discover key step for regulating embryonic development
4. Scientists sever molecular signals that prolific parasite uses to puppeteer cells
5. Scientists create artificial human skin with biomechanical properties using tissue engineering
6. Brown scientists elected to American Academy of Arts and Sciences
7. Scripps Research scientists reveal how genetic mutations may cause type 1 diabetes
8. 2 Hopkins scientists awarded European honorary doctorates
9. Chinese scientists discover marker indicating the developmental potential of stem cells
10. Scientists find new genes for cancer, other diseases in plants, yeast and worms
11. Scripps Research scientists solve mystery of fragile stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists favor needles over tablets for global vaccinations
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: